Global Transportation Battery Industry Research Report 2024-2028 Featuring BYD Co, Samsung SDI, GS Yuasa Corp, Johnsons Controls, and Exide Technologies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Transportation Battery Market, Size, Global Forecast 2024-2028, Industry Trends, Growth, Impact of Inflation, Opportunity... Read more.
No Redesign Required: StratEdge Revives Critical Hybrid Packages
Sustainable and cost-effective approach to maintaining vital defense, military, and aerospace applications SANTEE, Calif.–(BUSINESS WIRE)–#5G—StratEdge... Read more.
Corebridge Financial Announces Fourth Quarter and Full Year 2023 Results
Fourth Quarter Premiums and deposits1 of $10.5 billion, a 20% increase over the prior year quarter Base spread income2 of $987 million, a 21% increase over the prior... Read more.
The GEO Group Reports Fourth Quarter and Full Year 2023 Results
BOCA RATON, Fla.–(BUSINESS WIRE)–The GEO Group, Inc. (NYSE: GEO) (“GEO”), a leading provider of support services for secure facilities, processing... Read more.
Walker & Dunlop Reports Results for Q4 2023
Strongest Quarterly Results of the Year Driven by Highest Transaction Volume of 2023 FOURTH QUARTER 2023 HIGHLIGHTS Total transaction volume of $9.3 billion, down... Read more.
Genesis Energy, L.P. Reports Fourth Quarter 2023 Results
HOUSTON–(BUSINESS WIRE)–Genesis Energy, L.P. (NYSE: GEL) today announced its fourth quarter results. We generated the following financial results for... Read more.
Aurinia Discloses 2023 Year-End Financial and Operational Results, Announces Corporate Actions Focused on Enhancing Shareholder Value
Total net revenue was $45.1 million and $175.5 million, and net product revenue was $42.3 million and $158.5 million, for the fourth quarter and full year 2023,... Read more.
ScioTeq Expands Operations into Bangalore, India for Advanced Visualization & Computing Displays
Newest global location to provide equipment assembly, sales and service KORTRIJK, Belgium–(BUSINESS WIRE)–ScioTeq, a leading provider of mission-critical... Read more.
Q2 FY24 Results: Mytheresa posts positive growth and strong financial results outperforming a consolidating market
Solid Growth with Net Sales growing +8.3% on a constant currency basis (+3.6% on an IFRS basis) despite challenging macro environment in Q2 FY24 US Market Outperformance... Read more.
Osivax Announces Vaccination of First Participant in First-in-Human Trial Evaluating Sarbecovirus Vaccine Candidate OVX033
Phase 1 study to evaluate safety and immunogenicity of sarbecovirus (coronavirus) vaccine candidate, OVX033, at ascending dose levels The trial will enroll 48 participants... Read more.